Biotechnology research and development laboratories or services · Massachusetts

CRISPR Therapeutics

Boston, MA · ~397 workers · 2 years of OSHA Injury Tracking Application data.

C
Average Safety Record
0.0
Avg TCR
0.5
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

CRISPR Therapeutics runs at 0% of its industry's injury rate - about level with the typical Biotechnology research and development laboratories or services workplace, earning a grade C.

CRISPR Therapeutics: 0.0 TCR = 0% of Biotechnology research and development laboratories or services BLS 0.5 · 2y Form 300A (see methodology below)

CRISPR Therapeutics safety composite

CRISPR Therapeutics scores strongest on total case rate (tcr) (safer than 100% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

B

79/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
A 0 per 100 workers

Safer than 100% of industry peers

DART rate
B 0 per 100 workers

Safer than 76% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

CRISPR Therapeutics held a steady TCR band

CRISPR Therapeutics's TCR held near 0.0 from 0.0 in 2023 to 0.0 in 2024. Peak filing year was 2023 at 0.0 TCR.

2023=0.0 · 2024=0.0

OSHA ITA Form 300A scorecard

Establishment book 541711 · Boston, MA AT/BELOW-IND · MID

Grade C · TCR 0.0 · 0% of ind

  • DART 0.0 DART
  • RANK #0/23
  • PHOTO GSK/ViiV- Durham
  • BOOK 2y book
  • INJ 0 inj
  • SIZE ~397 FTE

Nearest TCR peer: GSK/ViiV- Durham (0.1 TCR gap)

Read with this employer → · Industry book → · Massachusetts employers → · Look up another →

CRISPR Therapeutics in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows CRISPR Therapeutics averages 0.0 TCR (0% of the Biotechnology research and development laboratories or services BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

CRISPR Therapeutics TCR series: 2023=0 · 2024=0 · BLS 0.5

Where CRISPR Therapeutics falls in its industry

189 Biotechnology research and dev establishments

Safer than 100% of graded establishments in this industry, whose median TCR is 0.8.

More dangerous than peersSafer than peers

Narrower to Massachusetts alone (the establishments it most directly competes with for workers and contracts): ranked #0 safest of 23 Biotechnology research and dev employers in Massachusetts.

CRISPR Therapeutics (397 employees, TCR 0.0) among 29 same-industry peers, split at the industry median of 296 employees and a TCR of 0.8 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,0005,000 05101520 Average employees Total Case Rate CRISPR Therapeutics
CRISPR Therapeutics (397 employees, TCR 0.0) among 29 same-industry peers, split at the industry median of 296 employees and a TCR of 0.8

CRISPR Therapeutics has more employees than the Biotechnology research and development l median and a lower injury rate than the industry's median TCR of 0.8. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 0.0 0.0 0 0 0
2023 0.0 0.0 0 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

541711 · MA · Boston

189 Biotechnology research and development laboratories or services employers nationwide with a credible TCR · 10,108 rated employers in Massachusetts with headcount on file · 577 employers in Boston, MA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR GSK/ViiV- Durham 0.1 TCR
NAICS-TCR Syngenta Crop Protection, LLC. 0.1 TCR
NAICS-TCR International Flavors and Fragrances 0.1 TCR
NAICS-TCR Thermo Fisher Scientific 0.1 TCR
STATE-SIZE Symbotic Headquarters 397 FTE
STATE-SIZE ASSOCIATED PHYSICIANS OF HMFP 397 FTE
STATE-SIZE WORC SOUTHBRIDGE STREET-MA61 398 FTE
STATE-SIZE ADESA 396 FTE
CITY-NEAR Massachusetts General Hospital 26,855 FTE
CITY-NEAR Brigham and Women's Hospital 19,183 FTE
CITY-NEAR Brigham and Womens Hospital 19,004 FTE
CITY-NEAR Brigham & Women's Hospital 18,260 FTE
NAT-TCR 2000 St James Place 0.0 TCR
NAT-TCR Pegasus Painting & Waterproofing LLC. 0.0 TCR
NAT-TCR Bilow Farms, LLC 0.0 TCR
NAT-TCR Lake Shore Electric Corp 0.0 TCR
NAT-SIZE Home Office 397 FTE
NAT-SIZE SSA Santa Ana Regional Center AP 397 FTE
NAT-SIZE Independent Options 397 FTE
NAT-SIZE JusticeWorks YouthCare 397 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.